Antipodes Partners’s Henry Schein HSIC Stock Holding History
Bought
Maintained
Sold
Other funds holding HSIC
KKRC
Antipodes Partners's HSIC Position: Q4 2025 in Review
Antipodes Partners sold out of Henry Schein (HSIC) in Q4 2025, closing a stake of 632 shares — an estimated $41.9K sold.
Antipodes Partners first reported a position in HSIC in Q4 2022 and held it in 7 quarters. The position peaked at $65K in Q4 2022. 544 funds tracked by Wall St. Rank hold HSIC as of Q4 2025.
- Antipodes Partners reported no remaining Henry Schein position as of Q4 2025 after selling out during the quarter.
- Antipodes Partners sold 632 Henry Schein shares in Q4 2025, an estimated $41.9K.
- Antipodes Partners first reported a position in Henry Schein in Q4 2022 and held it in 7 quarters.
- Antipodes Partners's Henry Schein position peaked at $65K in Q4 2022.
- 544 funds tracked by Wall St. Rank held Henry Schein as of Q4 2025.
Based on Antipodes Partners's 13F filing for Q4 2025, filed 5 Feb 2026.